Selectis Health (GBCS) Cash from Financing Activities (2017 - 2025)
Selectis Health's Cash from Financing Activities history spans 14 years, with the latest figure at $42335.0 for Q4 2025.
- Quarterly results put Cash from Financing Activities at $42335.0 for Q4 2025, up 1549.2% from a year ago — trailing twelve months through Dec 2025 was -$976692.0 (up 36.46% YoY), and the annual figure for FY2025 was -$976692.0, up 36.46%.
- Cash from Financing Activities for Q4 2025 was $42335.0 at Selectis Health, up from -$383707.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.1 million in Q4 2023 to a low of -$1.0 million in Q3 2023.
- The 5-year median for Cash from Financing Activities is -$171808.0 (2024), against an average of -$168808.8.
- The sharpest move saw Cash from Financing Activities plummeted 765.7% in 2022, then surged 1549.2% in 2025.
- Year by year, Cash from Financing Activities stood at -$128705.0 in 2021, then crashed by 519.61% to -$797467.0 in 2022, then soared by 236.62% to $1.1 million in 2023, then tumbled by 99.76% to $2567.0 in 2024, then surged by 1549.2% to $42335.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods came in at $42335.0, -$383707.0, and -$452881.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.